BIO-UV GROUP SAS (ALTUV.PA) Fundamental Analysis & Valuation

EPA:ALTUV • FR0013345493

1.308 EUR
0 (-0.15%)
Last: Mar 6, 2026, 07:00 PM

This ALTUV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall ALTUV gets a fundamental rating of 4 out of 10. We evaluated ALTUV against 109 industry peers in the Machinery industry. ALTUV has only an average score on both its financial health and profitability. ALTUV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. ALTUV.PA Profitability Analysis

1.1 Basic Checks

  • ALTUV had positive earnings in the past year.
  • In the past year ALTUV had a positive cash flow from operations.
  • ALTUV had positive earnings in each of the past 5 years.
  • Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • With a Return On Assets value of 1.36%, ALTUV is not doing good in the industry: 62.39% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of 2.41%, ALTUV is doing worse than 68.81% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.84%, ALTUV is doing worse than 69.72% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.83%.
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 2.64%, ALTUV perfoms like the industry average, outperforming 44.95% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALTUV has declined.
  • Looking at the Operating Margin, with a value of 5.93%, ALTUV is in line with its industry, outperforming 49.54% of the companies in the same industry.
  • ALTUV's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 38.14%, ALTUV perfoms like the industry average, outperforming 45.87% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALTUV has grown nicely.
Industry RankSector Rank
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. ALTUV.PA Health Analysis

2.1 Basic Checks

  • ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ALTUV has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALTUV has more shares outstanding
  • Compared to 1 year ago, ALTUV has an improved debt to assets ratio.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALTUV has an Altman-Z score of 1.37. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
  • ALTUV has a Altman-Z score of 1.37. This is in the lower half of the industry: ALTUV underperforms 67.89% of its industry peers.
  • ALTUV has a debt to FCF ratio of 7.69. This is a slightly negative value and a sign of low solvency as ALTUV would need 7.69 years to pay back of all of its debts.
  • ALTUV has a Debt to FCF ratio (7.69) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
  • ALTUV has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: ALTUV outperforms 46.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Altman-Z 1.37
ROIC/WACC0.39
WACC7.19%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.05 indicates that ALTUV has no problem at all paying its short term obligations.
  • ALTUV has a Current ratio of 2.05. This is in the better half of the industry: ALTUV outperforms 78.90% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
  • ALTUV has a better Quick ratio (1.31) than 74.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. ALTUV.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 190.18% over the past year.
  • ALTUV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.42% yearly.
  • ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -7.99%.
  • The Revenue has been growing by 14.65% on average over the past years. This is quite good.
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

  • ALTUV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.91% yearly.
  • Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 1.00% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

4

4. ALTUV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALTUV is valuated rather expensively with a Price/Earnings ratio of 18.69.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALTUV indicates a somewhat cheap valuation: ALTUV is cheaper than 71.56% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, ALTUV is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 18.14, the valuation of ALTUV can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALTUV.
  • The average S&P500 Price/Forward Earnings ratio is at 24.60. ALTUV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.69
Fwd PE 18.14
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTUV indicates a somewhat cheap valuation: ALTUV is cheaper than 63.30% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaper than 85.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.74
EV/EBITDA 8.27
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.29%
EPS Next 3Y11.91%

4

5. ALTUV.PA Dividend Analysis

5.1 Amount

  • ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
  • ALTUV's Dividend Yield is rather good when compared to the industry average which is at 1.45. ALTUV pays more dividend than 83.49% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALTUV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

ALTUV.PA Fundamentals: All Metrics, Ratios and Statistics

BIO-UV GROUP SAS

EPA:ALTUV (3/6/2026, 7:00:00 PM)

1.308

0 (-0.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-18
Earnings (Next)04-08
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.51M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target2.55 (94.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.67%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.69
Fwd PE 18.14
P/S 0.49
P/FCF 6.74
P/OCF 3.88
P/B 0.45
P/tB 3.61
EV/EBITDA 8.27
EPS(TTM)0.07
EY5.35%
EPS(NY)0.07
Fwd EY5.51%
FCF(TTM)0.19
FCFY14.84%
OCF(TTM)0.34
OCFY25.76%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROCE 3.87%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.55%
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.26%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Debt/EBITDA 3.38
Cap/Depr 79.6%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 99.7%
Profit Quality 275.52%
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.37
F-Score7
WACC7.19%
ROIC/WACC0.39
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A
EBIT growth 1Y9.21%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status of BIO-UV GROUP SAS (ALTUV.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for BIO-UV GROUP SAS?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


What is the valuation of BIO-UV GROUP SAS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIO-UV GROUP SAS (ALTUV.PA) is 18.69 and the Price/Book (PB) ratio is 0.45.


What is the financial health of BIO-UV GROUP SAS (ALTUV.PA) stock?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.